AWARDS

The Crystal Mortar Award-2023

   11th International Drug Chemistry Conference organized by Turkish Chemists Society, Crystal Mortar Awards in all 7 categories.


Pharmaceutical Active Substance Manufacturers – Congress Special Award

2021 Pharmaceutical R&D Expenditure – First Prize

2021 Pharmaceutical R&D Number of Employees – First Prize

2021 Pharmaceutical R&D Number of Female Employees – First Prize

2021 Pharmaceuticals R&D Number of Employees with Postgraduate & Doctorate – First Prize

2021 Pharmaceuticals R&D Number of Projects – Second Prize

2021 Pharmaceuticals R&D Number of Brands– Third Prize

The Golden Mortar Award-2022

   Received recognition as the best R&D company of the year for a project on "From Pazopanib Hydrochloride Active Ingredient Synthesis to Medicinal Product (Product Development by Vertical Integration)" in the Golden Mortar Awards, recognizing accomplished organizations, institutions and individuals in the pharmaceuticals industry.

 

 

The 11th Chemistry R&D Project Market Award-2022

      11th Chemistry R&D Project Market organized by Istanbul Chemicals and Chemical Products Exporters' Association (IKMIB), the first place in the pharmaceutical category with the project "Synthesis/Manufacture of the Active Pharmaceutical Agent Sugammadex Sodium, a Derivative of Neuromuscular Block Agent Gamma-Cyclodextrin".

 

 

The First Place in The Category of “By The Number Of Projects Conducted In The R&D Center”-2022
     10th International Drug Chemistry Conference organized by Turkish Chemists Society, among the pharmaceutical companies the first place in the category of “Pharmaceutical Company Conducting the Highest Number of Projects in the R&D Center in 2020”

 

 

 

 

The First Place in The Category of “The Highest R&D Expenses”-2022
     10th International Drug Chemistry Conference organized by Turkish Chemists Society, among the pharmaceutical companies the first place in the category of “Pharmaceutical Company with the Highest R&D Expenditure in 2020”

 

 

 

 

The First Place in the Category of “The Highest R&D Expenses”-2021

     9th International Drug Chemistry Conference organized by Turkish Chemists Society, among the pharmaceutical companies the first place in the category of “Pharmaceutical Company with the Highest R&D Expenditure in 2019”

 

 

 

 

The Third Place in the Category of “Pharmaceutical Company with the Highest Number of Brand Ownership by the R&D Center”-2021

    9th International Drug Chemistry Conference organized by Turkish Chemists Society, among the pharmaceutical companies third place in the category of “Pharmaceutical Company with The Highest Number Of Brand Ownership by the R&D Center in 2019”

 

 

 

 

 

The First Place in the Category of “By the Number of Projects Conducted in the R&D Center”-2021

    9th International Drug Chemistry Conference organized by Turkish Chemists Society, among the pharmaceutical companies the first place in the category of “Pharmaceutical Company Conducting the Highest Number of Projects in the R&D Center in 2019”

 

 

 

 

The First Place in The Pharmaceutical Industry Among The “Top 250 Companies With The Highest R&D Expenses”-2021
    TURKISHTIME Magazine, top twenty in overall ranking and the first place in the pharmaceutical industry among the “2021 Top 250 Companies With The Highest R&D Expenses”

 

 

 

 

The First Place in the Category of “By the Number of Projects Conducted in the R&D Center”-2020

    8th International Drug Chemistry Conference organized by Turkish Chemists Society, among the pharmaceutical companies the first places in the category of “Pharmaceutical Company Conducting the Highest Number of Projects in the R&D Center in 2018”

 

 

 

 

The First Place in The Pharmaceutical Industry Among The “Top 250 Companies With The Highest R&D Expenses”-2020
      TURKISHTIME Magazine, the first place in the pharmaceutical industry among the “2020 Top 250 Companies With The Highest R&D Expenses”

 

 

 

 

The First Place in The Pharmaceutical Industry Among The “Top 250 Companies With The Highest R&D Expenses”-2019
   TURKISHTIME Magazine, the first place in the pharmaceutical industry among the “2019 Top 250 Companies With The Highest R&D Expenses”

 

 

 

 

The First Place in The Pharmaceutical Industry Among The “Top 250 Companies With The Highest R&D Expenses”-2018
   TURKISHTIME Magazine, the first place in the pharmaceutical industry among the “2018 Top 250 Companies With The Highest R&D Expenses”

 

 

The Golden Mortar Award – 2017
      Received recognition as the best R&D company of the year for a project on “Lenalidomide for the Treatment of Patients with Multiple Myeloma, Mantle Cell Lymphoma and Myelodysplastic Syndrome” in the Golden Mortar Awards, recognizing accomplished organizations, institutions and individuals in the pharmaceuticals industry.
The Private Sector Best R&D Center Award – 2015
      Recognized as the best R&D company in the pharmaceutical industry at the 4th Private Sector R&D Centers Summit 2015, held by the Ministry of Science, Industry and Technology.
The Golden Mortar Award – 2015
      Received recognition as the best R&D company of the year for a project on “Manufactoring Active Pharmaceutical Ingredients for the Treatment of High Blood Pressure” in the Golden Mortar Awards, recognizing accomplished organizations, institutions and individuals in the pharmaceuticals industry.
The Golden Mortar Award – 2013
      Received recognition as the best R&D company of the year for a project on “Imatinib for the Treatment of CML” in the Golden Mortar Awards, recognizing accomplished organizations, institutions and individuals in the pharmaceuticals industry.